Opko Health | OPK - Sales Revenues

Opko Health reported $185.4M in Sales Revenues for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Sales Change
Abbott ABT:US USD 10.09B 319M
Acorda Therapeutics ACOR:US USD 31.47M 2.04M
Akebia Therapeutics AKBA:US USD 55.18M 6.22M
ALKERMES ALKS:US USD 304.67M 52.32M
Amarin AMRN:US USD 89.88M 4.56M
Arrowhead Research ARWR:US USD 62.55M 30.97M
Bluebird Bio BLUE:US USD 71K 1.45M
Bristol Myers Squibb BMY:US USD 11.41B 188M
Esperion Therapeutics ESPR:US USD 18.82M 162K
Exelixis EXEL:US USD 423.92M 12.18M
Laboratory Of America LH:US USD 3.67B 68.1M
Neurocrine Biosciences NBIX:US USD 412M 24.1M
Opko Health OPK:US USD 185.4M 5.66M
Quest Diagnostics DGX:US USD 2.33B 153M
Seattle Genetics SGEN:US USD 528.15M 17.85M
Teva Pharmaceutical Industries TEVA:US USD 3.88B 289M
Ultragenyx Pharmaceutical RARE:US USD 103.35M 12.64M